| EANM/SNMMI guideline for 18F-FDG use in inflammation and infection F Jamar, J Buscombe, A Chiti, PE Christian, D Delbeke, KJ Donohoe, ... Journal of Nuclear Medicine 54 (4), 647-658, 2013 | 579 | 2013 |
| Carcinoid tumour ME Caplin, JR Buscombe, AJ Hilson, AL Jones, AF Watkinson, ... The Lancet 352 (9130), 799-805, 1998 | 517 | 1998 |
| Radioguided sentinel lymph node biopsy in breast cancer surgery G Mariani, L Moresco, G Viale, G Villa, M Bagnasco, G Canavese, ... Journal of Nuclear Medicine 42 (8), 1198-1215, 2001 | 443 | 2001 |
| Detection of Atherosclerotic Inflammation by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging JM Tarkin, FR Joshi, NR Evans, MM Chowdhury, NL Figg, AV Shah, ... Journal of the American College of Cardiology 69 (14), 1774-1791, 2017 | 389 | 2017 |
| 111In-and 90Y-DOTA-lanreotide: results and implications of the MAURITIUS trial I Virgolini, K Britton, J Buscombe, R Moncayo, G Paganelli, P Riva Seminars in nuclear medicine 32 (2), 148-155, 2002 | 324 | 2002 |
| 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging E Bombardieri, F Giammarile, C Aktolun, RP Baum, AB Delaloye, ... European journal of nuclear medicine and molecular imaging 37 (12), 2436-2446, 2010 | 268 | 2010 |
| 67Ga scintigraphy: procedure guidelines for tumour imaging E BOMBARDIERL, C AKTOLUN, RP BAUM, A BISHOL-DELALOYE, ... European journal of nuclear medecine and molecular imaging 30 (12), BP125-BP131, 2003 | 226* | 2003 |
| 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging E Bombardieri, V Ambrosini, C Aktolun, RP Baum, A Bishof-Delaloye, ... European journal of nuclear medicine and molecular imaging 37 (7), 1441-1448, 2010 | 202 | 2010 |
| Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study JB Cwikla, A Sankowski, N Seklecka, JR Buscombe, ... Annals of Oncology 21 (4), 787-794, 2010 | 186 | 2010 |
| Long-term efficacy of high-activity 111in-pentetreotide therapy in patients with disseminated neuroendocrine tumors JR Buscombe, ME Caplin, AJW Hilson Journal of Nuclear Medicine 44 (1), 1-6, 2003 | 180 | 2003 |
| Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline A Signore, F Jamar, O Israel, J Buscombe, J Martín-Comín, E Lazzeri European Journal of Nuclear Medicine and Molecular Imaging 45, 1816-1831, 2018 | 172 | 2018 |
| Sentinel node in breast cancer procedural guidelines J Buscombe, G Paganelli, ZE Burak, W Waddington, J Maublant, E Prats, ... European journal of nuclear medicine and molecular imaging 34, 2154-2159, 2007 | 171 | 2007 |
| Assessment of osteoarthritis after reconstruction of the anterior cruciate ligament: a study using single-photon emission computed tomography at ten years AJ Hart, J Buscombe, A Malone, GSE Dowd The Journal of Bone & Joint Surgery British Volume 87 (11), 1483-1487, 2005 | 144 | 2005 |
| Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux PJ Dupont, E Psimenou, R Lord, JR Buscombe, AJ Hilson, P Sweny Transplantation 84 (3), 351-355, 2007 | 131 | 2007 |
| Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience J Garland, JR Buscombe, C Bouvier, P Bouloux, MH Chapman, AC Chow, ... Alimentary pharmacology & therapeutics 17 (3), 437-444, 2003 | 131 | 2003 |
| FDG-PET: procedure guidelines for tumour imaging E Bombardieri, C Aktolun, RP Baum, A Bishof-Delaloye, J Buscombe, ... European journal of nuclear medicine and molecular imaging 30 (12), B115-B124, 2003 | 119 | 2003 |
| Large-Volume Liver Metastases from Neuroendocrine Tumors: Hepatic Intraarterial 90Y-DOTA-Lanreotide as Effective Palliative Therapy1 MKG McStay, D Maudgil, M Williams, JM Tibballs, AF Watkinson, ... Radiology 237 (2), 718-726, 2005 | 111 | 2005 |
| 99mTc-human immunoglobulin (HIG) — first results of a new agent for the localization of infection and inflammation JR Buscombe, D Lui, G Ensing, R de Jong, PJ Ell European journal of nuclear medicine 16, 649-655, 1990 | 93 | 1990 |
| The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1 TC Booth, M Nathan, AD Waldman, AM Quigley, AH Schapira, ... American Journal of Neuroradiology 36 (2), 229-235, 2015 | 90 | 2015 |
| Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study P Bernal, JL Raoul, G Vidmar, E Sereegotov, FX Sundram, A Kumar, ... International Journal of Radiation Oncology* Biology* Physics 69 (5), 1448-1455, 2007 | 87 | 2007 |
Peter EllProfessor. UCL在 nhs.net 的电子邮件经过验证
